GovWire

Added clarification that publication was originally published by Public Health England.

##Chapter 1 The EQA schemeSection 1.3 EQA scheme enquiries updated contact information##Chapter 2 Scheme roles and responsibilities##Chapter 3 GovernanceSection 3.3 EQA Management BoardUpdated the EQA management boards escalation route for major concerns about the scheme (see last bullet)Section 3.4 National oversightUpdated the schemes accountability arrangements within NHS England##Chapter 4 Laboratory participationSection 4.7 ConfidentialityClarified the circumstances in which confidentiality (relating to a participant's identity) may be broken by the scheme.##Chapter 8 The assessmentSection 8.1 Recording and submitting responsesClarified the arrangements for participants who record and submit their responses using the manual form.Clarified the sanctions for participants who do not follow the protocol when submitting responses using EQA Online.##Chapter 11 Assessment of performanceSection 11.5 Action points for persistent substandard performanceThis update provides a detailed description of the steps taken by the scheme in relation to the first and second action points associated with instances of substandard performance in EQA assessments.##Chapter 12 CommunicationSection 12.8 Annual report updated the distribution list of recipients who receive the annual report

Updated 1.3 Enquiries and 3.4 National oversight sections. Added details of the changes to 'Changes to this edition of the gynaecological cytopathology EQA scheme'.

Updated to reflect various changes to this edition of the gynaecological cytopathology EQA scheme.

Eligibility criteria extended in section 2.2 for recruitment of a scheme organiser.

Updated 11th edition of guidance and removed unnecessary illustrations.

Updated guidance with 10th edition.

Ninth edition of guidance published March 2018.

Eighth edition, September 2017.

Seventh edition, published April 2017.

First published.